- US11687256utility2023Methods of Using OX40 Ligand Encoding Polynucleotides0 cites
- US11660341utility2023Mrna Combination Therapy for the Treatment of Cancer0 cites
- US11649461utility2023Polynucleotides Encoding Α-galactosidase a for the Treatment of Fabry Disease0 cites
- US11643441utility2023Nucleic Acid Vaccines for Varicella Zoster Virus (VZV)0 cites
- US11622972utility2023Lipid Nanoparticle Compositions and Methods of Formulating the Same0 cites
- US11603399utility2023Long-lived Polynucleotide Molecules0 cites
- US11596609utility2023Combinations of Mrnas Encoding Immune Modulating Polypeptides and Uses Thereof0 cites
- US11597698utility2023Branched Tail Lipid Compounds and Compositions for Intracellular Delivery of Therapeutic Agents0 cites
- US11590157utility2023Methods for Therapeutic Administration of Messenger Ribonucleic Acid Drugs0 cites
- US11583504utility2023Stabilized Formulations of Lipid Nanoparticles0 cites
- US11576961utility2023Broad Spectrum Influenza Virus Vaccine0 cites
- US11571463utility2023Polynucleotides Encoding Interleukin-12 (IL12) and Uses Thereof0 cites
- US11564893utility2023Methods for Preparing Particles and Related Compositions0 cites
- US11564998utility2023Modified Polynucleotides for the Production of Cytoplasmic and Cytoskeletal Proteins0 cites
- US11541113utility2023Human Cytomegalovirus Vaccine0 cites
← PreviousPage 5 of 5